Related Experiment Video
Updated: May 22, 2025

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Molecular Underpinnings of Brain Metastases
Maria A Jacome1, Qiong Wu2, Jianan Chen2
1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Abstract:
Brain metastases are the most commonly diagnosed type of central nervous system tumor, yet the mechanisms of their occurrence are still widely unknown. Lung cancer, breast cancer, and melanoma are the most common etiologies, but renal and colorectal cancers have also been described as metastasizing to the brain. Regardless of their origin, there are common mechanisms for progression to all types of brain metastases, such as the creation of a suitable tumor microenvironment in the brain, priming of tumor cells, adaptations to survive spreading in lymphatic and blood vessels, and development of mechanisms to penetrate the blood-brain barrier. However, there are complex genetic and molecular interactions that are specific to every type of primary tumor, making the understanding of the metastatic progression of tumors to the brain a challenging field of study. In this review, we aim to summarize current knowledge on the pathophysiology of brain metastases, from specific genetic characteristics of commonly metastatic tumors to the molecular and cellular mechanisms involved in progression to the central nervous system. We also briefly discuss current challenges in targeted therapies for brain metastases and how there is still a gap in knowledge that needs to be overcome to improve patient outcomes.
Insights
Brain metastases, common CNS tumors, arise from various cancers. Understanding their complex mechanisms, including tumor microenvironment and blood-brain barrier penetration, is crucial for developing effective treatments.
Area of Science:
- Neuro-oncology
- Cancer Metastasis Research
- Molecular Oncology
Background:
- Brain metastases represent the most frequent central nervous system tumors.
- Mechanisms underlying brain metastasis development remain largely unknown.
- Common primary sources include lung, breast, and melanoma, with renal and colorectal cancers also implicated.
Purpose of the Study:
- To review the current understanding of brain metastasis pathophysiology.
- To explore genetic characteristics of primary tumors and molecular mechanisms of CNS spread.
- To discuss challenges in targeted therapies and identify knowledge gaps.
Main Methods:
- Literature review synthesizing current research on brain metastases.
- Analysis of common and tumor-specific mechanisms of metastatic progression.
- Examination of genetic and molecular factors influencing central nervous system colonization.
Main Results:
- Common pathways include tumor microenvironment adaptation, cell priming, vascular survival, and blood-brain barrier penetration.
- Tumor-specific genetic and molecular interactions complicate metastatic progression.
- Significant challenges persist in developing targeted therapies for brain metastases.
Conclusions:
- A comprehensive understanding of brain metastasis pathophysiology requires integrating tumor-specific genetics with common metastatic mechanisms.
- Further research is needed to bridge knowledge gaps and improve therapeutic strategies for patients.
- Targeted therapies for brain metastases face hurdles due to complex underlying biology.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

